[PDF] Health-related Quality of Life in Patients with Sleep-Related Breathing Disorder
P Hessmann, J Heitmann, S Apelt, M Balzer-Geldsetzer… - J Sleep Disord Ther, 2017
... Obstructive sleep apnea (OSA) is a common sleep-related breathing disorder characterized by
intermittent apneas and hypopneas, leading to nocturnal hypoxemia, hypercapnia, arous-als,
and sleep fragmentation [1]. These nocturnal events negatively affect patients' daytime ...
intermittent apneas and hypopneas, leading to nocturnal hypoxemia, hypercapnia, arous-als,
and sleep fragmentation [1]. These nocturnal events negatively affect patients' daytime ...
 |  |  |
[PDF] Accuracy of the Oxford Sleep Resistance Test versus Simultaneous Electroencephalography to Detect Sleep Onset
V Jobin, A Mathieu, P Rompré, MP Brillon, G Rondeau - J Sleep Disord Ther, 2017
... used with 4 x 40 min trials and was first validated to determine sleep onset during daytime studies
with non- simultaneous EEG monitoring [3]. The OSLER discriminates well untreated sleepy
patients with obstructive sleep apnea (OSA) from normal controls [3]. Using different ...
with non- simultaneous EEG monitoring [3]. The OSLER discriminates well untreated sleepy
patients with obstructive sleep apnea (OSA) from normal controls [3]. Using different ...
| | |
[PDF] Egyptian Journal of Chest Diseases and Tuberculosis
LAEM Suliman, NE Morsy, AH El-Sebaie, NMAE Omar… - 2017
... Airway inflammation in OSA is mostly caused by release of inflammatory mediators due to
nocturnal apneas and hypopneas [13]. ... Please cite this article in press as: LA El M. Suliman et
al., Modelling obstructive sleep apnea susceptibility using non-invasive inflammatory ...
nocturnal apneas and hypopneas [13]. ... Please cite this article in press as: LA El M. Suliman et
al., Modelling obstructive sleep apnea susceptibility using non-invasive inflammatory ...
| | |
[PDF] Sleep and Neuromuscular Disease
S Sakamuri, JW Day - 2017
... when limited chest wall movement results in poor airflow and hypoxia, without observable
obstruction. ... This becomes even more apparent during REM sleep, when skeletal muscle tone
is ... These may be detected as obstructive or nonobstructive apneas ("pseudocentral," in that ...
obstruction. ... This becomes even more apparent during REM sleep, when skeletal muscle tone
is ... These may be detected as obstructive or nonobstructive apneas ("pseudocentral," in that ...
| | |
[PDF] The association between tinnitus and the risk of ischemic cerebrovascular disease in young and middle-aged patients: A secondary case-control analysis of a …
YS Huang, M Koo, JC Chen, JH Hwang - PLoS ONE, 2017
... kid- ney disease, chronic obstructive pulmonary disease, concussion or head trauma, conductive
hearing loss, diabetes mellitus, hyperlipidemia, hypertension, liver cirrhosis, malignant brain
tumor, Ménière's disease, obesity, obstructive sleep apnea, Parkinson's disease ...
hearing loss, diabetes mellitus, hyperlipidemia, hypertension, liver cirrhosis, malignant brain
tumor, Ménière's disease, obesity, obstructive sleep apnea, Parkinson's disease ...
| | |
[PDF] Trauma, Sepsis, Innate, Adaptive Immunity and Inflammation
M Frieri, K Kumar, A Boutin - MJ Immu, 2017
... Treatment options in mild obstructive sleep apnea includes continuous positive airway pressure
(CPAP) and oral appliance therapy, in addition to po ... and reduces exacerbations in patients with
severe uncontrolled asthma and also in chronic airflow obstruction phenotype [33]. ...
(CPAP) and oral appliance therapy, in addition to po ... and reduces exacerbations in patients with
severe uncontrolled asthma and also in chronic airflow obstruction phenotype [33]. ...
| | |
[PDF] Chronic Kidney Disease-Mineral Bone Disease (CKD-MBD) and Cardiac Arrest Risk Factors among Renal Failure Patients
AE Azab, ASI Elsayed - J Appl Biotechnol Bioeng, 2017
... The potential factors increasing the risk for sudden cardiac arrest in patients with CKD include
fluid overload, cardiomyopathy, ischemic heart disease, corrected QT interval dispersion,
sympathetic over activity, obstructive sleep apnea, baroreflex ineffectiveness, inflammation ...
fluid overload, cardiomyopathy, ischemic heart disease, corrected QT interval dispersion,
sympathetic over activity, obstructive sleep apnea, baroreflex ineffectiveness, inflammation ...
| | |
[PDF] Diabetes Autoantibodies Mediate Neural-and Endothelial Cell-Inhibitory Effects Via 5-Hydroxytryptamine-2 Receptor Coupled to Phospholipase C/Inositol …
MB Zimering - J Endocrinol Diab, 2017
... Methods: Protein-A eluates from plasma of 11 diabetic patients having nephropathy,
moderate-severe obesity and/or complications in which increased inflammation plays a role
(depression, Parkinson's disease, atrial fibrillation, obstructive sleep apnea) were tested for neurite ...
moderate-severe obesity and/or complications in which increased inflammation plays a role
(depression, Parkinson's disease, atrial fibrillation, obstructive sleep apnea) were tested for neurite ...
| | |
[PDF] Dental aspects of children with Down syndrome
A Vesna, AS Ivkovska, N Stavreva - J Dent Probl Solut, 2017
... cardiovascular disease, seizures [1], leukemia[2,3], infections with hepatitis B virus (especially
within institutionalized men)[4], upper respiratory tract infections [5], Alzheimer's disease[6], obesity
[7], thyroid diseases [8], cardiac anomalies [9], and obstructive sleep apnea [10,11]. ...
within institutionalized men)[4], upper respiratory tract infections [5], Alzheimer's disease[6], obesity
[7], thyroid diseases [8], cardiac anomalies [9], and obstructive sleep apnea [10,11]. ...
| | |
[PDF] Rule Out Normal Tension Glaucoma in a Young Woman
JC Chou, RM Mallery, LR Pasquale - Glauc Open Access, 2017
... There was no significant ocular history. Her medical history was remarkable for pulmonary
lymphangioleiomyomatosis (LAM) and obstructive sleep apnea. Medications included leuprorelin
and fulvestrant, both anti-estrogen drugs used in the treatment of LAM. ...
lymphangioleiomyomatosis (LAM) and obstructive sleep apnea. Medications included leuprorelin
and fulvestrant, both anti-estrogen drugs used in the treatment of LAM. ...
| | |
Αυτή η Ειδοποίηση του Μελετητή Google σας προσφέρεται από τη Google
Ακύρωση ειδοποίησης
Δημιουργία λίστας των ειδοποιήσεών μου
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου